Litcius/Paper detail

Dual-target inhibitors of bromodomain-containing protein 4 (BRD4) in cancer therapy: Current situation and future directions

Wenke Jin, Huidan Tan, Junhao Wu, Gu He, Bo Liu

2021Drug Discovery Today49 citationsDOI

Topics & Concepts

BromodomainBRD4Cancer therapyDrug discoveryComputational biologyCancerCancer researchChemistryBioinformaticsMedicineBiologyBiochemistryHistoneGeneticsGeneProtein Degradation and InhibitorsMultiple Myeloma Research and TreatmentsHistone Deacetylase Inhibitors Research
Dual-target inhibitors of bromodomain-containing protein 4 (BRD4) in cancer therapy: Current situation and future directions | Litcius